Alzheimer's Association Research Grant For All (AARGA) 2026: Up to $200,000 Over Three Years for Newly Independent Dementia Researchers

Alzheimer’s Association Research Grant For All (AARGA) 2026: Up to $200,000 Over Three Years for Newly Independent Dementia Researchers

There is a specific and uncomfortable gap in a dementia researcher’s career: the moment you become an assistant professor. You have your own lab, your own name on the door, and a hiring committee’s expectation that you will land an R01. What you do not have is the preliminary data that makes an R01 fundable. The Alzheimer’s Association Research Grant For All — AARGA — exists to close that gap. It provides up to $200,000 across two or three years so newly independent investigators can generate pilot data, test procedures, and sharpen hypotheses into something a federal study section will take seriously.

The 2026 cycle is open now. The letter of intent is due 14 August 2026 at 5 p.m. ET, the full application is due 14 October 2026 at 5 p.m. ET, and award notifications go out by 30 January 2027. The letter of intent is not optional and the deadline is not negotiable: the Association states plainly that applications will not be accepted without an approved LOI submitted within that grant cycle, and that late LOIs will not be accepted, with no exceptions.

Key details at a glance

What the money is actually for

Read the program’s stated purpose closely, because it shapes everything about how you should write the proposal. AARGA funds work “that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses,” with the explicit intent of laying “the groundwork for future research grant applications to federal or other funding entities.”

That is a bridge grant with a named destination. The Association is not asking you to complete a definitive study on $200,000 — that would be an unserious ask at this budget. It is asking you to de-risk something. A reviewer reading your application is implicitly asking: two years from now, will this person have a stronger federal application than they have today, and will it be stronger because of this money?

The budget structure reinforces the point. At $70,000 per year including indirects, this is a supplement to an existing environment, not a lab-founding award. It pays for a technician’s partial effort, a cohort of animals, an imaging block, a sequencing run, a modest recruitment push, an analyst’s time. It does not pay for your salary in any meaningful way, and it will not stand up an entirely new experimental platform from scratch. Proposals that budget as if this were an R01 read as though the applicant did not check the numbers.

The 10% indirect cap deserves an early conversation with your sponsored programs office. Many U.S. institutions negotiate federal rates north of 50%, and departments differ in how willingly they waive the difference for foundation awards. That waiver is routine for Alzheimer’s Association grants, but “routine” still means paperwork and a signature, and the person who signs it may be on vacation in mid-August. Start that thread before the LOI, not after the award.

Who fits, and who does not

The eligibility rules are unusually crisp, which is helpful — you can determine your own eligibility in about ninety seconds.

You need a doctoral degree (Ph.D. or equivalent) and a full-time Assistant Professor position, or the equivalent, at a not-for-profit academic, medical, or research institution. Research Assistant Professor titles count as equivalent, and here is the trap worth reading twice: any time spent in such a role counts toward the seven-year limit. Investigators who spent three years as a Research Assistant Professor before converting to a tenure-track Assistant Professor line have burned three of their seven years. If your CV has a soft-money faculty title in it, do the arithmetic against your LOI date of 14 August 2026 rather than against your tenure clock.

Only one primary principal investigator is permitted per proposal. Multiple-PI structures are not allowed, though collaborators and key personnel are welcome and, for most projects, expected. If your project is genuinely co-led, one of you has to be the PI on paper — decide that early, because it affects how the whole narrative is voiced.

For-profit organizations are not eligible. Non-profit public or private research laboratories, medical centers, hospitals, and universities are.

The program is genuinely international. The Association’s grant program welcomes applications from U.S. and international researchers, and encourages researchers from low- and middle-income countries to apply. The “For All” family of mechanisms is the Association’s open-to-anyone track, and the geographic breadth is real rather than decorative.

One eligibility line on the official page is self-referential and, as written, ambiguous: it says applicants are permitted a single application to “either this program or the Alzheimer’s Association Research Grants for All (AARGA) or the Alzheimer’s Association Clinical Scientist Fellowship for All (AACSFA)” in a given cycle. The clear intent is a one-application-per-cycle rule across the “For All” mechanisms — AARGA, the Research Fellowship For All (AARFA), and the Clinician Scientist Fellowship For All (AACSFA), all of which share the 14 August 2026 LOI deadline. If you are weighing two of these against each other, download the RFA and confirm with [email protected] before you submit. Do not assume you can hedge by applying to two.

Scope: what kinds of projects are in bounds

AARGA is deliberately catholic about subject matter. Applications are welcome from all areas of Alzheimer’s and related dementia research, including basic science, translational studies, clinical research, and psychosocial investigations. The Association names disease mechanisms, biomarker development, therapeutic targets, epidemiology, neuroimaging, care interventions, and health equity research as example topics.

“Related dementias” is doing real work in that sentence. Vascular contributions to cognitive impairment, Lewy body disease, frontotemporal dementia, and mixed pathologies all sit inside the portfolio. So does research that never touches a pipette: a care-delivery intervention for rural caregivers, a study of diagnostic delay in a specific population, or work on measurement validity in an underrepresented cohort are all recognizable AARGA projects.

What this breadth means practically is that you will not be competing solely against people who do exactly what you do. Your reviewers may include a health services researcher and a molecular neuroscientist in the same panel. Write the significance section so that a smart scientist two subfields away understands why the question matters, then let the approach section carry the technical weight.

The application process, step by step

Register on ProposalCentral first. Everything moves through proposalcentral.com. New users must register and build a Professional Profile, and that profile takes longer than people expect — it wants degrees, positions, publications, and other support. Do it in July, not on 13 August.

Submit the letter of intent by 14 August 2026, 5 p.m. ET. The LOI is the gate. Hard copies are not accepted. There are no extensions. Treat 5 p.m. ET as a hard wall and target the morning of the 13th, because ProposalCentral, like every grants portal, gets slow on deadline day.

Download and read the RFA. The AARGA page links a downloadable RFA that carries the full program objectives, detailed eligibility language, submission requirements, and review criteria. Anything in this guide is a summary; the RFA governs. Read it before you draft, and re-read the budget and eligibility sections before you submit.

Register as a reviewer. The Association requires applicants to be registered as reviewers, and reviewers are expected to evaluate at least one proposal outside their own competition. This is a genuine obligation, not a checkbox — plan for the time.

Note the terms-and-conditions clause. By submitting an LOI or application, your organization acknowledges it has reviewed the program’s terms and conditions of award and agrees to accept them as written. The Association states these conditions are non-negotiable. Your research administration office should see them before submission, not during award negotiation, because there will be no award negotiation.

Submit the full application by 14 October 2026, 5 p.m. ET. Two months separate the LOI from the full application. That is enough time if you start immediately and not enough if you wait for LOI feedback.

How the review works

The Association runs a multi-stage peer review through an online system.

In the first stage, a minimum of three peer scientists evaluate and rate each application. Applicants may recommend reviewers and may request exclusion of individuals with conflicts of interest — use both. Suggesting reviewers who understand your model system or your study population is one of the few levers you control, and flagging a genuine conflict is far better than hoping it goes unnoticed.

In the second stage, the International Research Grant Program Council and invited reviewers discuss the scores and make funding recommendations. The Medical and Scientific Advisory Group then conducts a final review for Association approval. Notification comes by email to the address in your application, by 30 January 2027.

Two implications follow from that structure. First, your primary reviewers write the summary that the Council discusses, so clarity for a non-specialist matters at the discussion stage. Second, this is a foundation with a mission, and mission fit is a live consideration alongside scientific merit. Say explicitly how the work connects to Alzheimer’s or a related dementia. Do not make a reviewer infer it.

Preparation strategy and common mistakes

Name the federal application this grant leads to. The program’s stated intent is groundwork for future federal or other funding applications. Write that sentence into your proposal: which mechanism, which agency, roughly when, and what specific gap in your current preliminary data this award fills. Applicants who leave this implicit lose the single clearest argument in their favor.

Scope to the money. Three aims at $70,000 a year is a red flag. One well-powered aim with a defined deliverable and a realistic contingency reads as competence. Reviewers have seen enough over-promised pilots to discount them automatically.

Check the seven-year clock against every title you have held. This is the most common disqualifier in mechanisms written this way, and it is entirely avoidable.

Resolve the indirect cost waiver early. Ten percent is well below most negotiated rates. Institutional sign-off is the step most likely to slip past a deadline you cannot extend.

Decide the PI question before you draft. Single primary PI only. A proposal that reads as co-led but lists one PI creates avoidable confusion about who is accountable.

Do not stack applications across the For All mechanisms. Given the one-per-cycle language and the shared 14 August LOI date, pick the mechanism that matches your career stage — AARGA for assistant professors, AARFA for postdoctoral researchers, AACSFA for practicing clinicians — and commit to it.

Frequently asked questions

Do I need to be at a U.S. institution? No. The grant is open to U.S. and international researchers at not-for-profit institutions, and the Association encourages applications from low- and middle-income countries.

Can I skip the letter of intent if my application is ready? No. Applications are not accepted without an approved LOI submitted within the same grant cycle, and late LOIs are refused without exception.

Can I request the full $200,000 for a two-year project? No. The annual cap is $70,000 including indirect costs, so a two-year project tops out near $140,000. Reaching $200,000 requires three years.

Does a Research Assistant Professor appointment count against eligibility? Yes. The program states explicitly that time in such a role counts toward the seven-year limit.

Can my company or startup apply? No. For-profit organizations are not eligible. Eligible applicants are non-profit public or private research laboratories, medical centers, hospitals, and universities.

When would funding actually start? Awards begin within three months of the award notification, which arrives by 30 January 2027. Plan for a spring 2027 start.

Are collaborators allowed? Yes. Collaborators and key personnel may be included; only the multiple-PI structure is prohibited.

Official links and next steps

• Program page: Alzheimer’s Association Research Grant For All (AARGA)
• All grant mechanisms: Types of Grants
• Process and review: How to Apply for a Research Grant
• Submission portal: ProposalCentral
• Questions: [email protected]

If you meet the seven-year test, the sequence for the next two weeks is straightforward: download the RFA from the AARGA page, confirm your ProposalCentral profile is complete, start the indirect cost waiver conversation with your sponsored programs office, and draft the LOI around a single aim with a named federal follow-on. The 14 August 2026 deadline is a hard wall with an explicit no-exceptions policy, and missing it costs you the entire cycle — the next LOI window will not open until well into 2027.